Bartels Bart, Habets Laura E, Stam Marloes, Wadman Renske I, Wijngaarde Camiel A, Schoenmakers Marja A G C, Takken Tim, Hulzebos Erik H J, van der Pol W Ludo, de Groot Janke F
Child Development and Exercise Center, Wilhelmina Children's Hospital, University Medical Center Utrecht, PO Box 85090, KB 02.056.0, 3508, AB, Utrecht, The Netherlands.
Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands.
BMC Neurol. 2019 Feb 9;19(1):21. doi: 10.1186/s12883-019-1244-3.
Fatigability has emerged as an important dimension of physical impairment in patients with Spinal Muscular Atrophy (SMA). At present reliable and valid outcome measures for both mildly and severely affected patients are lacking. Therefore the primary aim of this study is the development of clinical outcome measures for fatigability in patients with SMA across the range of severity.
We developed a set of endurance tests using five methodological steps as recommended by the 'COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN). In this iterative process, data from multiple sources were triangulated including a scoping review of scientific literature, input from a scientific and clinical multidisciplinary expert panel and three pilot studies including healthy persons (N = 9), paediatric patients with chronic disorders (N = 10) and patients with SMA (N = 15).
Fatigability in SMA was operationalised as the decline in physical performance. The following test criteria were established; one method of testing for patients with SMA type 2-4, a set of outcome measures that mimic daily life activities, a submaximal test protocol of repetitive activities over a longer period; external regulation of pace. The scoping review did not generate suitable outcome measures. We therefore adapted the Endurance Shuttle Walk Test for ambulatory patients and developed the Endurance Shuttle Box and Block Test and the - Nine Hole Peg Test for fatigability testing of proximal and distal arm function. Content validity was established through input from experts and patients. Pilot testing showed that the set of endurance tests are comprehensible, feasible and meet all predefined test criteria.
The development of this comprehensive set of endurance tests is a pivotal step to address fatigability in patients with SMA.
疲劳已成为脊髓性肌萎缩症(SMA)患者身体损伤的一个重要方面。目前,缺乏针对轻度和重度患者的可靠且有效的结局指标。因此,本研究的主要目的是开发适用于不同严重程度SMA患者疲劳的临床结局指标。
我们按照“基于共识的健康测量工具选择标准(COSMIN)”推荐的五个方法步骤,开发了一套耐力测试。在这个迭代过程中,对来自多个来源的数据进行了三角验证,包括对科学文献的范围综述、科学和临床多学科专家小组的意见以及三项试点研究,其中包括健康人(N = 9)、患有慢性疾病的儿科患者(N = 10)和SMA患者(N = 15)。
SMA患者的疲劳表现为身体机能下降。确定了以下测试标准:一种针对2 - 4型SMA患者的测试方法、一组模拟日常生活活动的结局指标、一个较长时间段内重复活动的次最大测试方案、步速外部调节。范围综述未产生合适的结局指标。因此,我们对可步行患者采用了耐力穿梭步行测试,并开发了耐力穿梭积木测试以及用于近端和远端手臂功能疲劳测试的九孔插板测试。通过专家和患者的意见确定了内容效度。试点测试表明,这套耐力测试易于理解、可行且符合所有预先定义的测试标准。
这套全面的耐力测试的开发是解决SMA患者疲劳问题的关键一步。